Clinical trials: Docosahexaenoic Acid
Dyslipidemia
An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels
The investigators aim to test the hypothesis that dietary supplementation with VASCAZEN will correct omega-3 deficiency in cardiac rehab patients and improve biochemical risk factors.
- Trial name
- CARE (NCT02052986)
- Testing
- VASCAZEN
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- New York Hospital Queens
Healthy Diet
Bioavailability and Pharmacodynamics of EPA and DHA From Fortified Soymilk and Capsules
This study will compare the algae oil fortified soymilk to a commercial algae oil capsule containing the same base oil with the goal of demonstrating equivalent or greater accumulation of EPA and DHA in blood lipid pools.
- Trial name
- NCT05802797
- Testing
- Algae Oil Fortified Soymilk, Algae Oil Capsule
- Where
- United States
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Ohio State University Comprehensive Cancer Center